 |
| Pill Millipede |
Pill millipedes are so called because they roll in to a ball when disturbed and this roll looks like a pill as you can see from the above photo, which is the works of
george francis. These millipedes are comparatively short and usually has about eleven to thirteen body segments. You might find
Pill millipedes in wet woodlands, not in DomoPharma.
But when you
search for the drug Millipred, on DomoPharma, you will be presented with more information with the support of DomoDrugs. Such as,
What is Millipred;
"Millipred Oral Solution (10 mg Prednisolone per 5 mL)
is a dye free, pale to light yellow solution. Each 5 mL (teaspoonful) of
Millipred Oral Solution contains 13.4 mg prednisolone sodium phosphate
(10 mg prednisolone base) in a palatable, aqueous vehicle.
Inactive Ingredients: Millipred Oral Solution (10 mg Prednisolone per
5 mL) contains the following inactive ingredients: anti-bitter mask,
corn syrup, edetate disodium, glycerin, grape flavor,
hydroxyethylcellulose, methylparaben, potassium phosphate dibasic,
potassium phosphate monobasic, purified water, and sodium saccharin."
What is used for; (Basically it decreases your immune system's response to various diseases to
reduce symptoms such as pain, swelling and allergic-type reactions.)
"Millipred Oral Solution (10 mg Prednisolone per 5 mL) is indicated in the following conditions:
1. Allergic States
Control
of severe or incapacitating allergic conditions intractable to adequate
trials of conventional treatment in adult and pediatric populations
with: seasonal or perennial allergic rhinitis; asthma; contact
dermatitis; atopic dermatitis; serum sickness; drug hypersensitivity
reactions.
2. Dermatologic Diseases
Pemphigus;
bullous dermatitis herpetiformis; severe erythema multiforme
(Stevens-Johnson syndrome); exfoliative erythroderma; mycosis fungoides.
3. Edematous States
To
induce diuresis or remission of proteinuria in nephrotic syndrome in
adults with lupus erythematosus and in adults and pediatric populations,
with idiopathic nephrotic syndrome, without uremia.
4. Endocrine Disorders
Primary
or secondary adrenocortical insufficiency (hydrocortisone or cortisone
is the first choice; synthetic analogs may be used in conjunction with
mineralocorticoids where applicable; in infancy mineralocorticoid
supplementation is of particular importance); congenital adrenal
hyperplasia; hypercalcemia associated with cancer; nonsuppurative
thyroiditis.
5. Gastrointestinal Diseases
To tide the patient over a critical period of the disease in: ulcerative colitis; regional enteritis.
6. Hematologic Disorders
Idiopathic
thrombocytopenic purpura in adults; selected cases of secondary
thrombocytopenia; acquired (autoimmune) hemolytic anemia; pure red cell
aplasia; Diamond-Blackfan anemia.
7. Neoplastic Diseases
For the treatment of acute leukemia and aggressive lymphomas in adults and children.
8. Nervous System
Acute exacerbations of multiple sclerosis.
9. Ophthalmic Diseases
Uveitis and ocular inflammatory conditions unresponsive to topical corticosteroids; temporal arteritis; sympathetic ophthalmia.
10. Respiratory Diseases
Symptomatic
sarcoidosis; idiopathic eosinophilic pneumonias; fulminating or
disseminated pulmonary tuberculosis when used concurrently with
appropriate antituberculous chemotherapy; asthma (as distinct from
allergic asthma listed above under “Allergic States”), hypersensitivity
pneumonitis, idiopathic pulmonary fibrosis, acute exacerbations of
chronic obstructive pulmonary disease (COPD), and Pneumocystis carinii
pneumonia (PCP) associated with hypoxemia occurring in an HIV (+)
individual who is also under treatment with appropriate anti-PCP
antibiotics. Studies support the efficacy of systemic corticosteroids
for the treatment of these conditions: allergic bronchopulmonary
aspergillosis, idiopathic bronchiolitis obliterans with organizing
pneumonia.
11. Rheumatic Disorders
As
adjunctive therapy for short term administration (to tide the patient
over an acute episode or exacerbation) in: psoriatic arthritis;
rheumatoid arthritis, including juvenile rheumatoid arthritis (selected
cases may require low dose maintenance therapy); ankylosing spondylitis;
acute and subacute bursitis; acute nonspecific tenosynovitis; acute
gouty arthritis; epicondylitis. For the treatment of systemic lupus
erythematosus, dermatomyositis (polymyositis), polymyalgia rheumatica,
Sjogren’s syndrome, relapsing polychondritis, and certain cases of
vasculitis.
12. Miscellaneous
Tuberculous
meningitis with subarachnoid block or impending block, tuberculosis
with enlarged mediastinal lymph nodes causing respiratory difficulty,
and tuberculosis with pleural or pericardial effusion (appropriate
antituberculous chemotherapy must be used concurrently when treating any
tuberculosis complications); trichinosis with neurologic or myocardial
involvement; acute or chronic solid organ rejection (with or without
other agents)."
Including how the label looks like;
PRINCIPAL DISPLAY PANEL — 237 mL Bottle Label
NDC 16477-510-08
Millipred™
(Prednisolone Sodium Phosphate
Oral Solution)
Equivalent to prednisolone
10 mg/5 mL
ALCOHOL FREE / DYE FREE
Rx Only
8 fl oz (237 mL)
LASER
MILLIPRED
prednisolone sodium phosphate solution |
|
|
|
|
|
|
|
|
|
|
|
Revised: 09/2009 Laser Pharmaceuticals, LLC
No comments:
Post a Comment